Mathur says she's worked with colleagues at Cedars-Sinai to create a protocol for patients who need the medication to continue to keep blood sugars stabilized
Other common reasons include BMI documented more than 30 days ago, comorbidity not supported by lab data, or prescriber not in network
,,Garca-VillalnAL,AmorSMongeLet al.In vitro studies of an aged black garlic extract enriched in S-allylcysteine and polyphenols with cardioprotective effects.2016;27:189200 66
[15] [16] Note that febuxostat carries additional cautions for people with established cardiovascular disease
Summary Stopping a GLP-1 medication doesn't have to mean starting from scratch
By harnessing the predictive power of AI, we will gain deeper insights into placebo and treatment responses, advancing precision medicine in PDN